Original Research
Accepted on 16 May 2025
Efficacy and safety of Eribulin-based Chemotherapy in HER2 negative advanced breast cancer patients: A Real-World Study
in Breast Cancer
- 174 views
Original Research
Accepted on 16 May 2025
in Breast Cancer
Original Research
Published on 16 May 2025
in Breast Cancer
Case Report
Published on 16 May 2025
in Breast Cancer
Original Research
Published on 16 May 2025
in Breast Cancer
Original Research
Accepted on 15 May 2025
in Breast Cancer
Original Research
Accepted on 15 May 2025
in Breast Cancer
Review
Accepted on 15 May 2025
in Breast Cancer
Original Research
Accepted on 15 May 2025
in Breast Cancer
Original Research
Accepted on 14 May 2025
in Breast Cancer
Original Research
Published on 14 May 2025
in Breast Cancer
Original Research
Published on 14 May 2025
in Breast Cancer
Original Research
Published on 14 May 2025
in Breast Cancer
Mini Review
Accepted on 13 May 2025
in Breast Cancer
Original Research
Accepted on 13 May 2025
in Breast Cancer
Systematic Review
Published on 13 May 2025
in Breast Cancer
Original Research
Published on 12 May 2025
in Breast Cancer